Evolus Academy

Propelling Knowledge, Clinical Techniques, And Optimal Outcomes.

More events coming soon

NUCEIVA^® (prabotulinumtoxinA)

PBS Information: This product is not listed on the PBS.

Evolus QR

This medicinal product is subject to additional monitoring in Australia. This will allow quick identification of new safety information. Healthcare professionals are asked to report any suspected adverse events at www.tga.gov.au/reporting-problems

Please review the full Product Information before prescribing. Product Information is available by scanning the QR code or by calling 1800 749 137.

AU-P-2600009 | February 2026 Evolus Australia Pty Ltd, North Sydney, NSW.

THIS TRAINING IS ORGANISED AND SPONSORED BY EVOLUS FOR HEALTHCARE PROFESSIONALS ONLY.

Please note: This is a non-promotional educational event intended for medical professionals only.

Evolus products will be discussed at this meeting.

NUCEIVA^® (prabotulinumtoxinA) is approved by Australia's Therapeutic Goods Administration (TGA) for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients.